Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment? (vol 11, pg 1216, 2016)

被引:0
|
作者
Santiago, Marcelo F.
机构
关键词
D O I
10.4103/1673-5374.191231
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:1449 / 1449
页数:1
相关论文
共 33 条
  • [1] Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment?
    Gubert, Fernanda
    Satiago, Marcelo F.
    NEURAL REGENERATION RESEARCH, 2016, 11 (08) : 1216 - 1219
  • [2] Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis:how far are we from a clinical treatment?
    Fernanda Gubert
    Marcelo F.Satiago
    Neural Regeneration Research, 2016, 11 (08) : 1216 - 1219
  • [3] Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis (vol 23, pg 45, 2016)
    Elia, A. E.
    Lalli, S.
    Monsurro, M. R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (04) : 659 - 659
  • [4] INTRATHECAL AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STEM CELL THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS
    Gabri, H.
    Kishk, N.
    Belal, E.
    Aboelfotooh, A.
    M, E.
    CYTOTHERAPY, 2017, 19 (05) : S121 - S122
  • [5] Bone-marrow mononuclear cell therapy in a mouse model of amyotrophic lateral sclerosis: Functional outcomes from different administration routes
    Gubert, Fernanda
    Bonacossa-Pereira, Igor
    Decotelli, Ana B.
    Furtado, Michelle
    Vasconcelos-dos-Santos, Andreia
    Mendez-Otero, Rosalia
    Santiago, Marcelo F.
    BRAIN RESEARCH, 2019, 1712 : 73 - 81
  • [6] Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis
    Fernanda Gubert
    Ana B. Decotelli
    Igor Bonacossa-Pereira
    Fernanda R. Figueiredo
    Camila Zaverucha-do-Valle
    Fernanda Tovar-Moll
    Luísa Hoffmann
    Turan P. Urmenyi
    Marcelo F. Santiago
    Rosalia Mendez-Otero
    Stem Cell Research & Therapy, 7
  • [7] Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis
    Gubert, Fernanda
    Decotelli, Ana B.
    Bonacossa-Pereira, Igor
    Figueiredo, Fernanda R.
    Zaverucha-do-Valle, Camila
    Tovar-Moll, Fernanda
    Hoffmann, Luisa
    Urmenyi, Turan P.
    Santiago, Marcelo F.
    Mendez-Otero, Rosalia
    STEM CELL RESEARCH & THERAPY, 2016, 7
  • [8] Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis
    Choi, Mi Ran
    Kim, Hyun Young
    Park, Ji-Yoon
    Lee, Tae Yong
    Baik, Cheong Soon
    Chai, Young Gyu
    Jung, Kyoung Hwa
    Park, Kyoung Sun
    Roh, Wonjae
    Kim, Kyung Suk
    Kim, Seung Hyun
    NEUROSCIENCE LETTERS, 2010, 472 (02) : 94 - 98
  • [9] Preliminary Results of a Phase I-II Clinical Trial on the Use of Bone Marrow Mononuclear Cells in the Treatment of Amyotrophic Lateral Sclerosis
    Blanquer, M.
    Iniesta, F.
    Ruiz, F. R.
    Meca, J.
    Espuch, J. Gomez
    Villaverde, R.
    Santos, J. M. Garcia
    del Rio, S. Torres
    Funes, C.
    Izura, V.
    Casado, P. de Mingo
    Salinas, A. Sanchez
    Saez, V.
    Carles, R.
    Antunez, C.
    Moreau, L. Vivancos
    Palazon, J. Hernandez
    Bleda, P.
    Majado, M. J.
    Espejo, M. A. Perez
    Martinez, S.
    Moraleda, J. M.
    HUMAN GENE THERAPY, 2009, 20 (09) : 1036 - 1036
  • [10] Bone Marrow-Derived Stromal Cells from Amyotrophic Lateral Sclerosis Patients Have Diminished Stem Cell Capacity
    Koh, Seong-Ho
    Lee, Kyu-Yong
    Lee, Young J.
    Cho, Goang W.
    Kim, Seung H.
    Kim, Juhan
    NEUROLOGY, 2011, 76 (09) : A44 - A44